Splitting: the road to precision medicine in IPF?

E. White (Ann Arbor, United States of America)

Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis
Session: New Horizons in The Treatment of Pulmonary Fibrosis
Session type: Evening Symposium
Number: 3430
Disease area: -

Webcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. White (Ann Arbor, United States of America). Splitting: the road to precision medicine in IPF?. International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Precision medicine in COPD: where are we and where do we need to go?
Source: Eur Respir Rev, 27 (149) 180022; 10.1183/16000617.0022-2018
Year: 2018



What is precision medicine?
Source: Eur Respir J, 50 (4) 1700391; 10.1183/13993003.00391-2017
Year: 2017



Time to breathe: Progress in precision medicine in cystic fibrosis
Source: Short video discussion 2022
Year: 2022

COPD: Still a Cinderella?
Source: Eur Respir J 2003; 22: Suppl. 45, 67s
Year: 2003

Individual trajectory-based care for COPD: getting closer, but not there yet
Source: ERJ Open Res, 7 (4) 00451-2021; 10.1183/23120541.00451-2021
Year: 2021



Personalised medicine: how ready are we for this?
Source: Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare
Year: 2013


Lung cancer assessment clinics: the fast track to bad news?
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Translational perspectives in paediatric OSA: Guts and particles lead the way!
Source: ERS webinar 2021: Translational perspectives in paediatric OSA: Guts and particles lead the way!
Year: 2021

Lessons from sports medicine: can we give our patients ‘doping’?
Source: Annual Congress 2009 - PG20 State of the art in pulmonary rehabilitation
Year: 2009



Epigenetics and pulmonary diseases in the horizon of precision medicine: a review
Source: Eur Respir J, 57 (6) 2003406; 10.1183/13993003.03406-2020
Year: 2021



Personalised medicine: are we ready?
Source: Eur Respir Rev, 26 (145) 170088; 10.1183/16000617.0088-2017
Year: 2017



E-learning course on COPD prevention for Russian GP: what do the doctors say?
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007


COPD in farmers: what have we learnt?
Source: Eur Respir J 2016; 47: 16-18
Year: 2016


“To define is to limit”: perspectives on asthma–COPD overlap syndrome and personalised medicine
Source: Eur Respir J, 49 (5) 1700336; 10.1183/13993003.00336-2017
Year: 2017



Precision medicine in airway diseases: moving to clinical practice
Source: Eur Respir J, 50 (4) 1701655; 10.1183/13993003.01655-2017
Year: 2017



What’s new in paediatric asthma?
Source: International Congress 2018 – Paediatric Year in Review
Year: 2018


COPD: time to improve its taxonomy?
Source: ERJ Open Res, 4 (1) 00132-2017; 10.1183/23120541.00132-2017
Year: 2018



Introduction to precision medicine in COPD
Source: Eur Respir J, 53 (4) 1802460; 10.1183/13993003.02460-2018
Year: 2019



Linking clinical algorithms to precision medicine
Source: Virtual Congress 2020 – Precision endotyping of asthma: time for action
Year: 2020